| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/24/2007 | US7246596 Control system for internal combustion engine |
| 07/24/2007 | US7246528 Toner evaluation method, toner cartridge, and image forming apparatus |
| 07/24/2007 | CA2393731C Sperm quality assay |
| 07/24/2007 | CA2370315C Encoding of microcarriers |
| 07/24/2007 | CA2280902C Automated immunoassay cassette |
| 07/24/2007 | CA2264436C Gas sensors |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2231799C Method and apparatus for mapping the condition of a wound |
| 07/24/2007 | CA2162134C Hepatitis-c virus type 4,5 and 6 |
| 07/24/2007 | CA2151236C Stably transfected cell lines expressing gaba-a receptors |
| 07/24/2007 | CA1341536C Transforming growth factor peptides |
| 07/24/2007 | CA1341535C Transforming growth factor peptides |
| 07/19/2007 | WO2007082302A2 Detection, separation or isolation of target molecules using a microchannel apparatus |
| 07/19/2007 | WO2007082181A2 Methods of modulating cell surface receptors to prevent or reduce inflammation |
| 07/19/2007 | WO2007082173A2 Compositions and methods for enhancing the identification of prion protein prpsc |
| 07/19/2007 | WO2007082154A2 B7-h1 and b7-h4 in cancer |
| 07/19/2007 | WO2007082144A2 B7-h1 and survivin in cancer |
| 07/19/2007 | WO2007082057A2 Lectin arrays and translational applications |
| 07/19/2007 | WO2007081969A2 Domain segmentation and analysis |
| 07/19/2007 | WO2007081968A1 Granularity analysis in cellular phenotypes |
| 07/19/2007 | WO2007081946A2 Method for the identification of drugs to treat stroke at delayed timepoints |
| 07/19/2007 | WO2007081868A1 Determination of concentration of fk778 by competitive immunoassay |
| 07/19/2007 | WO2007081851A2 Affinity chromatography matrices and methods of making and using the same |
| 07/19/2007 | WO2007081804A2 Regulators of nfat |
| 07/19/2007 | WO2007081790A2 Methods for diagnosing and treating prostate cancer |
| 07/19/2007 | WO2007081778A2 Multiplexed detection of anti-red cell alloantibodies |
| 07/19/2007 | WO2007081777A2 METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC |
| 07/19/2007 | WO2007081768A2 Use of he4 and other biochemical markers for assessment of ovarian cancers |
| 07/19/2007 | WO2007081767A2 Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers |
| 07/19/2007 | WO2007081716A2 Self-illuminating quantum dot systems and methods of use thereof |
| 07/19/2007 | WO2007081610A1 Liquid-particle analysis of metal materials |
| 07/19/2007 | WO2007081565A2 Ammonia sensor and system for use |
| 07/19/2007 | WO2007081543A2 High-throughput cell-based assays fabricated with integrated silicon and cell culture technologies |
| 07/19/2007 | WO2007081520A2 Methods for characterizing molecular interactions |
| 07/19/2007 | WO2007081387A1 Microfluidic devices, methods of use, and kits for performing diagnostics |
| 07/19/2007 | WO2007081385A2 Microfluidic devices and methods of use in the formation and control of nanoreactors |
| 07/19/2007 | WO2007081330A1 Device and method for immunoassays |
| 07/19/2007 | WO2007081306A1 Method for the detection of stress biomarkers including cortisol by fluorescence polarization |
| 07/19/2007 | WO2007080761A1 Probe array substrate, method of producing the same and method of producing probe array |
| 07/19/2007 | WO2007080710A1 Mouse deficient in vesicular gaba transporter gene |
| 07/19/2007 | WO2007080621A1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 07/19/2007 | WO2007080593A2 Siva ubiquitination and/or degradation-related activity and modulators thereof |
| 07/19/2007 | WO2007080415A1 Detecting a chemical impurity |
| 07/19/2007 | WO2007080381A1 Gas sensor |
| 07/19/2007 | WO2007080274A1 Antibody characterization test |
| 07/19/2007 | WO2007080245A1 Method of discriminating at least two cell populations, and application |
| 07/19/2007 | WO2007080157A1 Apparatus and method for in situ measuring of evaporation from a surface |
| 07/19/2007 | WO2007080129A1 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
| 07/19/2007 | WO2007080123A1 Method for determining the concentration of virus particles/virus antigens |
| 07/19/2007 | WO2007080039A1 An in-vitro method for screening accessible biological markers in pathologic tissues |
| 07/19/2007 | WO2007079893A1 Device and method for identifying mycotoxins |
| 07/19/2007 | WO2007079581A1 Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carobxylase |
| 07/19/2007 | WO2007079546A1 PHOSPHORYLATED Sp1 ANTIBODIES |
| 07/19/2007 | WO2007079516A2 Sensor device and method for monitoring a fuel cell system |
| 07/19/2007 | WO2007079508A1 Method and device for determining the condition of biological material, in particular foodstuffs |
| 07/19/2007 | WO2007062628A3 Immunoassay for the simultaneous immunochemical determination of an analyte (antigen) and a treatment antibody targeting the analyte in samples (recovery immunoassay) |
| 07/19/2007 | WO2007058965A9 P66-shc as predictive marker in cancer treatment |
| 07/19/2007 | WO2007058860A9 Mrhos as modifiers of the rho pathway and methods of use |
| 07/19/2007 | WO2007055275B1 Method of estimating development of hepatitis c virus-related hepatocellular cancer in future, decision tree to be used in the method and method of constructing the decision tree |
| 07/19/2007 | WO2007051207A3 Kinase and ubiquination assays |
| 07/19/2007 | WO2007049264A3 Assays using nanoparticles |
| 07/19/2007 | WO2007045481A3 A system and method for the determination of an electrical characteristic of a liquid |
| 07/19/2007 | WO2007044594A3 Motion invariant generalized hyperspectral targeting and identification methodology and apparatus therefor |
| 07/19/2007 | WO2007033367A3 Salivary protein and rna for breast cancer detection |
| 07/19/2007 | WO2007028530A9 Method for diagnosis of sepsis with apolipoprotein a1 |
| 07/19/2007 | WO2007015177A8 In vitro diagnostic method and kit for an aspergillus infection |
| 07/19/2007 | WO2007015174A3 Exosome-specific ligands, their preparartion and uses |
| 07/19/2007 | WO2007013124A3 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
| 07/19/2007 | WO2006116002A9 Tgf beta 1 specific antibodies |
| 07/19/2007 | WO2006115870A3 Multiplex microparticle system |
| 07/19/2007 | WO2006113703A8 Carboline derivatives useful in the treatment of cancer |
| 07/19/2007 | WO2006113529A3 Diagnosis of sepsis |
| 07/19/2007 | WO2006050159A3 Methods of predicting responsiveness to treatment |
| 07/19/2007 | WO2006034191A3 Tem17 binds to cortactin |
| 07/19/2007 | WO2006033691A3 Copy choice recombination and uses thereof |
| 07/19/2007 | WO2005079247A3 Synthetic calibration standard for photonic response of tissues |
| 07/19/2007 | WO2005033661A3 Dmbt1 as a clinical marker and uses thereof |
| 07/19/2007 | WO2005031302A3 Drug authentication |
| 07/19/2007 | WO2004092198A3 Compositions and methods for the modifying hypoxia induced gene regulation |
| 07/19/2007 | US20070169210 Modulators of gamete adhesion include polypeptides comprising at least one discoidin/C domain and optionally EGF domain; medical diagnosis; contraception; fertility |
| 07/19/2007 | US20070168145 Calibration of Sensors or Measuring Systems |
| 07/19/2007 | US20070167875 Method and apparatus for penetrating tissue |
| 07/19/2007 | US20070167874 Method and apparatus for penetrating tissue |
| 07/19/2007 | US20070167873 Method and apparatus for penetrating tissue |
| 07/19/2007 | US20070167872 Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| 07/19/2007 | US20070167871 Method and apparatus for penetrating tissue |
| 07/19/2007 | US20070167870 Method and apparatus for penetrating tissue |
| 07/19/2007 | US20070167854 Flow-independent parameter estimation based on tidal breathing exhalation profiles |
| 07/19/2007 | US20070167635 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/19/2007 | US20070167611 Peptides and Peptidomimetics with Structural Similarity to Human p53 that Activate p53 Function |
| 07/19/2007 | US20070167608 Sugar chain structure profiling techniques |
| 07/19/2007 | US20070167607 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/19/2007 | US20070167594 Affinity resin |
| 07/19/2007 | US20070167478 Biomarkers for sensitivity of proliferative diseases to mtor inhibitors |
| 07/19/2007 | US20070167405 Galectins -1 and -4 in tumor development |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166837 Nanoscale biomolecule sensor and method for operating same |